Outlook Therapeutics, Inc.
OTLK
$1.45
$0.085.84%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.70M | 14.93M | 32.02M | 47.23M | 10.36M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | 3.11M | -- | -- | -- | -- |
Prepaid Expenses | 6.86M | 12.49M | 13.59M | 10.56M | 10.03M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 15.67M | 27.42M | 45.62M | 57.79M | 20.39M |
|
|||||
Total Current Assets | 15.67M | 27.42M | 45.62M | 57.79M | 20.39M |
Net Property, Plant & Equipment | 262.80K | 274.60K | 286.50K | 3.70K | 15.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 416.00K | 439.30K | 479.20K | 473.20K | 484.30K |
Total Assets | 17.01M | 28.82M | 47.09M | 59.03M | 21.69M |
|
|||||
Total Accounts Payable | 12.19M | 7.97M | 5.55M | 4.36M | 3.48M |
Total Accrued Expenses | 3.39M | 3.24M | 2.68M | 3.12M | 4.09M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 30.80M | 29.49M | 32.46M | 44.75M | 36.55M |
Total Finance Division Other Current Liabilities | 1.86M | 1.86M | 1.86M | 1.86M | 1.86M |
Total Other Current Liabilities | 1.86M | 1.86M | 1.86M | 1.86M | 1.86M |
Total Current Liabilities | 48.24M | 42.55M | 42.55M | 54.08M | 45.97M |
|
|||||
Total Current Liabilities | 48.24M | 42.55M | 42.55M | 54.08M | 45.97M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 233.10K | 246.90K | 260.40K | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 18.83M | 59.10M | 87.95M | 139.18M | 59.60K |
Total Liabilities | 67.30M | 101.90M | 130.77M | 193.26M | 46.03M |
|
|||||
Common Stock & APIC | 475.62M | 470.21M | 465.30M | 459.15M | 454.75M |
Retained Earnings | -525.91M | -543.28M | -548.98M | -593.39M | -479.10M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -50.29M | -73.08M | -83.67M | -134.24M | -24.34M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -50.29M | -73.08M | -83.67M | -134.24M | -24.34M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -50.29M | -73.08M | -83.67M | -134.24M | -24.34M |
|